Skip to main content

Author: Customer Service

RENX ENTERPRISES CONFIRMS MICROTEC UTM 1200 TURBO MILL COMPLETED AND READY FOR SHIPMENT; APRIL DELIVERY EXPECTED AS SITE PREPARATION ADVANCES

MIAMI, FL , March 26, 2026 (GLOBE NEWSWIRE) — RenX Enterprises Corp. “RenX” (NASDAQ: RENX), a  biomass recycling, logistics, and real estate company, today announced that it has received written confirmation from MTDH Germany GmbH (“Microtec”) that the  UTM 1200 Turbo Mill ordered by the Company has been completed at the Microtec manufacturing facility and is being prepared for shipment from Germany to RenX’s Myakka City, Florida facility. Delivery to the site is expected in April 2026, as the Company works to finalize site preparation and coordinate installation logistics. The Microtec UTM 1200 is the primary size-reduction component of the Microtec milling system, a 12-step engineered processing circuit designed to process up to 10 tons per hour of woody biomass screened from compost and produce three specification-defined particle...

Continue reading

KULR ONE Battery Architecture Enters Electric Aviation: KULR Technology Group Signs Agreement with Robinson Helicopter as Battery Co-Developer for eR66 Electric Helicopter Demonstrator

HOUSTON and TORRANCE, Calif., March 26, 2026 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), the advanced battery intelligence solution for autonomous platforms, digital infrastructure, e-mobility, and spaceflight applications, today announces a strategic co-development collaboration with Robinson Helicopter Company (RHC), the world’s leading manufacturer of civil helicopters, to develop a next-generation, high-performance battery system for an eR66 battery-electric helicopter demonstrator.Under the agreement, KULR is expected to serve as a developer of the advanced battery system for the eR66 platform. The Company intends to design and integrate a lightweight, high-performance battery architecture using KULR’s proprietary battery safety technologies...

Continue reading

Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement

HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) — Pluri Inc. (“Pluri” or the “Company”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging a proprietary cell-based platform across multiple commercial verticals, today announced that an entity beneficially owned by Alejandro Weinstein, Chairman of the Board and one of the Company’s largest shareholders, has entered into a Securities Purchase Agreement with Pluri for an additional $2.5 million investment in the Company at a 30% premium to the market price on March 24, 2026. This additional investment follows Mr. Weinstein’s prior $2.5 million investment announced in connection with his appointment as Chairman of the Board, and further underscores his continued support in Pluri’s strategy, underlying asset base, and long-term value creation opportunity. “Making an additional...

Continue reading

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

– Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton Syndrome (NS) in the U.S. and Europe  – Advances Proposed Expedited Regulatory Approval Pathways in Japan and Saudi Arabia and Secures Fast Track Designation in the U.S. for QRX003 for NS Subsequent to the End of Q4 – Reports Continued Clinical Progress for QRX003 in Netherton Syndrome Clinical Studies including Data Supporting Longer Term Durable Treatment Effect and Safety Profile – Pediatric NS Study Expanded to 7 Children Now Actively Treated with QRX003, Largest Cohort of This Age Group Ever Studied – Ongoing Clinical Data Continues to Support Development of QRX003 as a Treatment for Peeling Skin Syndrome with Study Being Expanded to 6 Subjects – Proprietary Rapamycin Topical Platforms Achieve Target Loadings;...

Continue reading

Perma-Fix Awarded $24 Million Contract for Demolition and Disposal Project at Lawrence Livermore National Laboratory

Two-year master task agreement expands Perma-Fix’s nuclear services project portfolio and reinforces its long-standing relationship supporting work at LLNL ATLANTA, March 26, 2026 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced it has been awarded a two-year master task agreement valued at approximately $24 million by Lawrence Livermore National Security, LLC (“LLNS”) for demolition and disposal at Lawrence Livermore National Laboratory (“LLNL”) in Livermore, California. Under the agreement, Perma-Fix will provide demolition, excavation, and waste management services to support the safe disposition of these facilities as part of site efforts aligned with LLNL’s national security mission. The project is expected to draw on Perma-Fix’s technical expertise in complex radiological...

Continue reading

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) — CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the filing of two new patent applications that further expand the Company’s intellectual property portfolio surrounding tapinarof, a drug currently approved for the treatment of psoriasis and atopic dermatitis. The first newly filed patent covers a combination therapy pairing tapinarof with a class of drugs clinically proven in psoriasis and atopic dermatitis, while the second patent relates to novel cocrystal forms of tapinarof with these agents. CDT believes these developments may underpin a second-generation tapinarof product with enhanced formulation properties and potential efficacy benefits, creating an opportunity to extend the asset’s lifecycle and broaden its clinical and...

Continue reading

Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report

Company Positions for Growth with AI-Driven Media, Marketing, Digital Asset Expansion CHICAGO, March 26, 2026 (GLOBE NEWSWIRE) — via IBN — Alliance Creative Group, Inc., (http://www.ACGX.us),  a technology-driven holding company focused on AI-powered media, marketing, and digital assets (Stock Symbol OTC:ACGX) is pleased to announce the results of Operations for the Year Ending December 31, 2025. Gross Incomes for the Year ending December 31, 2025 (“2025”) were $364,082 Expenses for the Year ending December 31, 2025 (“2025”) were $282,813 Net Income for the Year ending December 31, 2025 (“2025”) was $81,269 The total assets on the Balance Sheet for the Alliance Creative Group as of 12/31/25 were $1,066,929 The total outstanding common shares as of December 31, 2025 were 7,006,143 with 4,225,903...

Continue reading

RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment

TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for Drug-Delivery in Oncology Management MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced the Company has achieved a key milestone in its ongoing Phase III TIGeR‑PaC clinical trial by surpassing 100 randomized patients and remains on track for enrollment completion in the first half of 2026, with final data expected in 2027. “Reaching over 100 randomized patients marks an important milestone in our Phase III...

Continue reading

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt

     According to the Rain Foundation, anyone using OpenClaw or other AI agents can generate a live prediction market via a single prompt to the agent, without manual coding or centralized gatekeepers      The Rain Foundation announced a $5 million grant program to support developers and creators worldwide in building, launching, and monetizing their own independent prediction markets via the Rain decentralized platform through AI agentsNes-Ziona, Israel, March 26, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”), a quality longevity company powered by a prediction markets treasury, today reported that the Rain Foundation, which independently oversees the decentralized prediction markets Rain protocol, announced the launch of its AI agent-ready interface and a $5 million grant program to support...

Continue reading

DeFi Development Corp. Announces Completion of March 2026 Community AMA

BOCA RATON, FL, March 26, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (“DFDV” or the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced the successful completion of its March 2026 community Ask Me Anything (AMA) session hosted on Reddit. The AMA, held on March 23, 2026, provided an open forum for the Company’s management team to engage directly with its community and investors. Topics discussed included DFDV’s treasury strategy, Solana ecosystem developments, validator operations, digital asset treasury (DAT) expansion initiatives, and ongoing product innovation across its onchain yield and tokenization efforts. The AMA can be accessed here: https://www.reddit.com/r/DFDVDegens/comments/1rx5ve5/mar_2026_official_dfdv_ama_ask_the_team_anything/. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.